# Pliant Therapeutics (PLRX) — Analyst Forecast

PLRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/plrx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 0 | 4 | 1 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Mar 13, 2026 | Canaccord Genuity | Maintained | Hold | $3.00 |
| Mar 12, 2026 | Piper Sandler | Maintained | Overweight | $3.00 |
| Nov 7, 2025 | RBC Capital | Maintained | Sector Perform | $2.00 |
| Oct 10, 2025 | JP Morgan | Downgraded | Neutral → Underweight | — |
| Aug 8, 2025 | Piper Sandler | Maintained | Overweight | $4.00 |
| Mar 18, 2025 | HC Wainwright & Co. | Maintained | Neutral | — |
| Mar 4, 2025 | Needham | Downgraded | Buy → Hold | $10.00 |
| Mar 4, 2025 | Wells Fargo | Maintained | Equal-Weight | $3.00 |
| Mar 4, 2025 | RBC Capital | Maintained | Sector Perform | $3.00 |
| Mar 4, 2025 | Cantor Fitzgerald | Maintained | Neutral | — |
| Mar 4, 2025 | Citigroup | Maintained | Neutral | $1.50 |
| Mar 4, 2025 | HC Wainwright & Co. | Maintained | Neutral | — |
| Feb 14, 2025 | Needham | Maintained | Buy | $10.00 |
| Feb 14, 2025 | HC Wainwright & Co. | Maintained | Neutral | — |
| Feb 10, 2025 | HC Wainwright & Co. | Downgraded | Buy → Neutral | — |
| Feb 10, 2025 | Needham | Maintained | Buy | $10.00 |
| Feb 10, 2025 | Citigroup | Downgraded | Buy → Neutral | $4.00 |
| Feb 10, 2025 | Wells Fargo | Downgraded | Overweight → Equal-Weight | $4.00 |
| Feb 10, 2025 | Canaccord Genuity | Downgraded | Buy → Hold | $4.00 |
| Feb 10, 2025 | RBC Capital | Downgraded | Outperform → Sector Perform | $4.00 |

## Frequently Asked Questions

### Is PLRX a buy, sell, or hold?

Analysts covering Pliant Therapeutics currently average a Hold rating: 0 buy, 4 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on PLRX?

On Mar 13, 2026, Canaccord Genuity maintained Pliant Therapeutics at Hold with a price target of $3.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).